To assess the generalizability of this correlation, we analyzed the correlation between RUNX2 and a gene signature composed of the identified lipid-related targets (Fig. 2F) using TC, BC, and prostate cancer datasets from TCGA [37]. The gene discussed is RUNX2; the disease is prostate carcinoma.